| |||||||||
|
37%
agree
|
Pipeline questions |
|
14%
agree
|
Medicare could negatively affect Abbott's pricing in the long run |
|
14%
agree
|
Abbott's R&D expenditures are much less than their competition |
![]()
|
|||||||||||||||||||
| ||||||